S'abonner

Ultrasound characteristics of early-stage high-grade serous ovarian cancer - 01/10/21

Doi : 10.1016/j.ajog.2021.04.262 
Elizabeth Suh-Burgmann, MD a, b, , Natasha Brasic, MD c, Priyanka Jha, MBBS d, Yun-Yi Hung, PhD b, Ruth B. Goldstein, MD d
a Division of Gynecologic Oncology, The Permanente Medical Group, Oakland, CA 
b Division of Research, Kaiser Permanente Northern California, Oakland, CA 
c Department of Radiology, The Permanente Medical Group, Oakland, CA 
d Department of Radiology, University of California, San Francisco, San Francisco, CA 

Corresponding author: Elizabeth Suh-Burgmann, MD.

Abstract

Background

Survival from ovarian cancer is strongly dependent on the stage at diagnosis. Therefore, when confronted with a woman with an isolated adnexal mass, clinicians worry about missing the opportunity to detect cancer at an early stage. High-grade serous ovarian cancers account for 80% of ovarian cancer deaths, largely because of their tendency to be diagnosed at a late stage. Among adnexal masses, large size and the presence of solid areas on ultrasound examination have been found to be associated with cancer, but it is unclear whether these characteristics identify early-stage cases.

Objective

This study aimed to evaluate the ultrasound findings associated with clinically detected early-stage high-grade serous ovarian cancer.

Study Design

This was a retrospective cohort study of women diagnosed with stage I or II high-grade serous ovarian or fallopian tube cancer measuring at least 1 cm at pathology from 2007 to 2017. Preoperative ultrasound examinations were independently reviewed by 3 radiologists. Adnexal masses were scored for size and volume; overall appearance; presence, thickness, and vascularity of septations; morphology and vascularity of other solid components; and degree of ascites. Characteristics were compared between masses of <5 cm and larger masses and between stage I and stage II cases. Interobserver variability was assessed.

Results

Among 111 women identified, 4 had bilateral ovarian involvement, for a total of 115 adnexal masses characterized by ultrasound examination. The mean age at diagnosis was 61.8 years (range, 42–91 years). The median mass size was 9.6 cm (range, 2.2–23.6 cm) with 87% of cases having a mass size of ≥5 cm. A mixed cystic and solid appearance was most common (77.4%), but a completely solid appearance was more frequently seen for tumors of <5 cm compared with larger tumors (26.7% vs 13.0%). Solid components other than septations were seen in 97.4% of cases. The characteristics of stage I and II cases were similar other than ascites, which was more commonly seen in stage II cases (18.0% vs 3.1%, respectively). Interobserver concordance was high for size and volume measurements (correlation coefficients, 0.96–0.99), with moderate agreement observed across the other ultrasound characteristics (Fleiss kappa, 0.45–0.58).

Conclusion

In this community-based cohort, early-stage high-grade serous cancers rarely presented as masses of <5 cm or masses without solid components other than septations. Our findings provide additional support for the observation of small masses without solid areas on ultrasound examination.

Le texte complet de cet article est disponible en PDF.

Key words : cancer, cyst, early detection, ovary, ultrasound


Plan


 This study was funded by the Kaiser Permanente Northern California Community Benefit Research Program and the Permanente Medical Group Physician Researcher Program.
 The authors report no conflict of interest.
 Cite this article as: Suh-Burgmann E, Brasic N, Jha P, et al. Ultrasound characteristics of early-stage high-grade serous ovarian cancer. Am J Obstet Gynecol 2021;225:409.e1-8.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 225 - N° 4

P. 409.e1-409.e8 - octobre 2021 Retour au numéro
Article précédent Article précédent
  • Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
  • Willem Jan van Weelden, Roy I. Lalisang, Johan Bulten, Kristina Lindemann, Heleen J. van Beekhuizen, Hans Trum, Dorry Boll, Henrica M.J. Werner, Luc R.C.W. van Lonkhuijzen, Refika Yigit, David Forsse, Petronella O. Witteveen, Khadra Galaal, Alexandra van Ginkel, Eliana Bignotti, Vit Weinberger, Sanne Sweegers, Judith R. Kroep, Silvia Cabrera, Marc P.L.M. Snijders, Márcia A. Inda, Ane Gerda Z. Eriksson, European Network for Individualized Treatment in Endometrial Cancer, Camilla Krakstad, Andrea Romano, Anja van de Stolpe, Johanna M.A. Pijnenborg
| Article suivant Article suivant
  • Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV
  • L. Stewart Massad, Xianhong Xie, Howard L. Minkoff, Katherine G. Michel, Gypsyamber D’Souza, Chia-Ching Wang, Deborah Konkle-Parker, Igho Ofotokun, Margaret A. Fischl, Lisa Rahangdale, Howard D. Strickler

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.